AQR CAPITAL MANAGEMENT LLC

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1167557 Greenwich, CT

Position in PHAT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$616,247

-$287,042 QoQ

Shares Held

55,468

+1.9% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. PHAT ranks #151 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$616,247	55,468	+1.9%	Shares	Other	2026-05-15
2025-12-31	$903,289	54,448	+3.5%	Shares	Other	2026-02-17
2025-09-30	$619,442	52,629	+5.4%	Shares	Other	2025-11-14
2025-06-30	$478,770	49,924	-53.5%	Shares	Other	2025-08-14
2025-03-31	$673,389	107,399	+508.2%	Shares	Other	2025-05-15
2024-12-31	$143,382	17,658	-4.2%	Shares	Defined	2025-02-14
2023-12-31	$168,238	18,427	-19.3%	Shares	Defined	2024-02-14
2023-09-30	$236,798	22,835	+127.3%	Shares	Defined	2023-11-14
2022-12-31	$112,716	10,046	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.